| 摘要 |
The present invention provides methods for reducing or inhibiting angiogenesis in a tissue, by contacting alpha5beta1 integrin in the tissue with an agent that interferes with specific binding of the alpha5beta1 integrin to a ligand expressed in the tissue. The invention further provides methods of reducing or inhibiting angiogenesis in a tissue in an individual, by administering to the individual an agent that interferes with the specific binding of alpha5beta1 integrin to a ligand expressed in the tissue; and methods of reducing the severity of a pathological condition associated with angiogenesis in an individual, by administering to the individual an agent that interferes with specific binding of alpha5beta1 integrin to a ligand in a tissue associated with the pathological condition.
|
